Acoustic Medsystems

Executive Summary

Acoustic MedSystems, Inc. (AMS) is a private medical device company pioneering image-guided, minimally and non-invasive therapeutic ultrasound systems for the precise treatment of localized soft tissue diseases and pain management. Founded in 2009 and headquartered in Champaign, Illinois, AMS operates at the intersection of cardiovascular and broader medical device sectors. Its proprietary technology leverages ultrasound energy delivered with high spatial precision, aiming to offer a non-surgical alternative for conditions such as cardiac arrhythmias, tumors, and chronic pain. By integrating real-time imaging with therapeutic delivery, AMS seeks to improve patient outcomes and reduce recovery times compared to conventional invasive procedures. The company remains privately held and has not disclosed its total funding, valuation, or specific development stage, indicating it may be in the later stages of preclinical or early clinical development.

Upcoming Catalysts (preview)

• TBDInitial Clinical Trial Results for Cardiac Ablation40% success
• TBDStrategic Partnership with Medical Device Distributor50% success
• TBDSeries C Funding Round45% success